Literature DB >> 3476800

Physiology of ADH secretion.

G L Robertson.   

Abstract

The past decade has witnessed continuing advances in our understanding of the physiology of vasopressin secretion. Despite some empirical and theoretical objections, linear regression analysis of the relationship between plasma vasopressin and plasma osmolality or sodium continues to provide a simple and useful way to describe the major functional properties of the osmoregulatory system. Recent studies employing this approach have shown that the sensitivity and "set" of the system can be altered independently, indicating that they have different bases and control mechanisms. All factors known to alter the sensitivity of the system also produce a reciprocal change in sensitivity to the antidiuretic action of vasopressin. This association suggests that the existence of some as yet unrecognized feedback signal that links the regulation of vasopressin secretion and action. The "set" of the osmoregulatory system appears subject to modification by a large number of physiologic and pathological variables, some of which may act directly or indirectly by endogenous opioids. Even the solute specificity of the osmoreceptor is subject to change since insulin deficiency significantly increases the stimulatory potency of hyperglycemia. A fuller understanding of the variables and mechanisms that alter the various properties of the osmoregulatory system will enhance management of clinical disorders of water balance and other diseases in which abnormalities in vasopressin secretion may play a role.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3476800

Source DB:  PubMed          Journal:  Kidney Int Suppl        ISSN: 0098-6577            Impact factor:   10.545


  15 in total

Review 1.  Familial forms of diabetes insipidus: clinical and molecular characteristics.

Authors:  Muriel Babey; Peter Kopp; Gary L Robertson
Journal:  Nat Rev Endocrinol       Date:  2011-07-05       Impact factor: 43.330

Review 2.  Crosstalk between the nervous system and the kidney.

Authors:  Shinji Tanaka; Mark D Okusa
Journal:  Kidney Int       Date:  2019-11-22       Impact factor: 10.612

3.  Hypertonic saline test for the investigation of posterior pituitary function.

Authors:  A Mohn; C L Acerini; T D Cheetham; S L Lightman; D B Dunger
Journal:  Arch Dis Child       Date:  1998-11       Impact factor: 3.791

Review 4.  Copeptin as a Diagnostic and Prognostic Biomarker in Cardiovascular Diseases.

Authors:  Danni Mu; Jin Cheng; Ling Qiu; Xinqi Cheng
Journal:  Front Cardiovasc Med       Date:  2022-07-04

5.  Defective Store-Operated Calcium Entry Causes Partial Nephrogenic Diabetes Insipidus.

Authors:  Mykola Mamenko; Isha Dhande; Viktor Tomilin; Oleg Zaika; Nabila Boukelmoune; Yaming Zhu; Manuel L Gonzalez-Garay; Oleh Pochynyuk; Peter A Doris
Journal:  J Am Soc Nephrol       Date:  2015-11-16       Impact factor: 10.121

Review 6.  Cell biology of vasopressin-regulated aquaporin-2 trafficking.

Authors:  Hanne B Moeller; Robert A Fenton
Journal:  Pflugers Arch       Date:  2012-06-29       Impact factor: 3.657

7.  Short-Term Tolvaptan Increases Water Intake and Effectively Decreases Urinary Calcium Oxalate, Calcium Phosphate and Uric Acid Supersaturations.

Authors:  Wisit Cheungpasitporn; Stephen B Erickson; Andrew D Rule; Felicity Enders; John C Lieske
Journal:  J Urol       Date:  2015-11-17       Impact factor: 7.450

Review 8.  Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis.

Authors:  Mirjam Christ-Crain; Wiebke Fenske
Journal:  Nat Rev Endocrinol       Date:  2016-01-22       Impact factor: 43.330

Review 9.  Nephrogenic diabetes insipidus: essential insights into the molecular background and potential therapies for treatment.

Authors:  Hanne B Moeller; Søren Rittig; Robert A Fenton
Journal:  Endocr Rev       Date:  2013-01-29       Impact factor: 19.871

Review 10.  Aortocaval fistula in rat: a unique model of volume-overload congestive heart failure and cardiac hypertrophy.

Authors:  Zaid Abassi; Ilia Goltsman; Tony Karram; Joseph Winaver; Aaron Hoffman
Journal:  J Biomed Biotechnol       Date:  2011-01-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.